|
Volumn 92, Issue SUPPL. 3, 2003, Pages 28-29
|
Clinical long-term results of H.E.L.P.-apheresis
|
Author keywords
Adverse effects; Angina pectoris; Cardiac endpoints; Clinical long term outcome; H.E.L.P; LDL Apheresis; Patients registry
|
Indexed keywords
ANTILIPEMIC AGENT;
HEPARIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
STATINE DERIVATIVE;
ANTICOAGULANT AGENT;
LOW DENSITY LIPOPROTEIN;
ANGINA PECTORIS;
ANGIOPLASTY;
APHERESIS;
ATHEROGENESIS;
CHOLESTEROL BLOOD LEVEL;
CORONARY ARTERY BYPASS GRAFT;
DIET THERAPY;
DYSPNEA;
FAMILIAL HYPERCHOLESTEROLEMIA;
HEALTH SURVEY;
HEART DEATH;
HEART DISEASE;
HEART INFARCTION;
HEPARIN INDUCED EXTRACORPOREAL LOW DENSITY LIPOPROTEIN PRECIPITATION;
HUMAN;
INCIDENCE;
MAJOR CLINICAL STUDY;
MARKETING;
PATIENT COMPLIANCE;
REGISTER;
REIMBURSEMENT;
SAFETY;
SELF REPORT;
SHORT SURVEY;
SIDE EFFECT;
TREATMENT OUTCOME;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
COMORBIDITY;
CORONARY ARTERY ATHEROSCLEROSIS;
EXTRACORPOREAL CIRCULATION;
FEMALE;
FOLLOW UP;
GERMANY;
HYPERCHOLESTEROLEMIA;
ISOLATION AND PURIFICATION;
LONGITUDINAL STUDY;
MALE;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
POSTMARKETING SURVEILLANCE;
PRECIPITATION;
STATISTICS;
ANTICOAGULANTS;
BLOOD COMPONENT REMOVAL;
CHOLESTEROL, LDL;
COMBINED MODALITY THERAPY;
COMORBIDITY;
CORONARY ARTERIOSCLEROSIS;
EXTRACORPOREAL CIRCULATION;
FEMALE;
FOLLOW-UP STUDIES;
GERMANY;
HEPARIN;
HUMANS;
HYPERCHOLESTEROLEMIA;
LIPOPROTEINS, LDL;
LONGITUDINAL STUDIES;
MALE;
PRECIPITATION;
PRODUCT SURVEILLANCE, POSTMARKETING;
TREATMENT OUTCOME;
|
EID: 0347132296
PISSN: 03005860
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (17)
|
References (0)
|